1928 Global Pharmaceuticals & Biotech Stocks - Strong Balance Sheet Stocks - Investing Ideas

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
VIGL Vigil Neuroscience	US$3.48	5.8%	-65.2%	US$122.8m	US$16.75	PB1.1x	E13.9%	n/a
LABS MediPharm Labs	CA$0.085	0%	6.3%	CA$34.3m	n/a	PS1x	E78.0%	n/a
RLYB Rallybio	US$1.67	-6.7%	-66.7%	US$61.6m	US$11.25	PB0.6x	E34.3%	n/a
THAR Tharimmune	US$0.44	-5.5%	-97.9%	US$5.3m	US$5.00	PB0.6x	n/a	n/a
SNSE Sensei Biotherapeutics	US$1.04	-1.4%	-32.4%	US$25.3m	US$4.67	PB0.4x	E-10.3%	n/a
PRME Prime Medicine	US$6.10	-9.8%	-50.4%	US$662.4m	US$13.86	PB5.3x	E-7.6%	n/a
LPCN Lipocine	US$5.26	-0.8%	0.5%	US$25.5m	US$33.00	PB1.4x	n/a	n/a
SCYX SCYNEXIS	US$1.63	9.4%	-50.6%	US$64.6m	US$6.88	PE0.9x	E-9.4%	n/a
ACRV Acrivon Therapeutics	US$5.91	-18.5%	-37.8%	US$146.7m	US$18.63	PB1.1x	E4.4%	n/a
HBP Helix BioPharma	CA$0.18	0%	-14.3%	CA$40.1m	n/a	PB62.7x	n/a	n/a
LBPH Longboard Pharmaceuticals	US$18.18	-13.6%	262.5%	US$649.9m	US$42.57	PB16x	E-0.09%	n/a
VCYT Veracyte	US$20.69	-4.4%	-2.9%	US$1.5b	US$31.67	PS4.3x	E115.2%	n/a
SLRN Acelyrin	US$6.05	-9.2%	n/a	US$597.1m	US$24.17	PB0.9x	E-0.8%	n/a
NMRA Neumora Therapeutics	US$14.70	5.5%	n/a	US$2.3b	US$25.38	PB5x	E-9.7%	n/a
PRLD Prelude Therapeutics	US$4.70	0.2%	-32.8%	US$258.0m	US$4.75	PB1.1x	E-9.4%	n/a
PCSA Processa Pharmaceuticals	US$2.99	27.0%	-70.2%	US$8.0m	US$4.00	PB1.7x	E36.9%	n/a
IGC IGC Pharma	US$0.62	30.3%	82.4%	US$42.9m	US$3.25	PS33.7x	E21.7%	n/a
GNLX Genelux	US$4.67	-10.9%	-83.1%	US$130.3m	US$26.00	PS726.1x	E28.7%	n/a
ZYME Zymeworks	US$9.62	-2.6%	2.7%	US$681.0m	US$14.17	PS8.9x	E2.2%	n/a
TRAW Traws Pharma	US$0.78	-21.6%	17.0%	US$17.0m	US$8.00	PS73.1x	E-18.9%	n/a
ALLK Allakos	US$1.13	-7.4%	-72.6%	US$104.6m	US$2.90	PB0.6x	E45.4%	n/a
MOJO Mojave Brands	CA$0.32	0%	33.3%	CA$3.0m	n/a	PB7.1x	n/a	n/a
NRBO NeuroBo Pharmaceuticals	US$3.97	-2.2%	-27.6%	US$19.0m	US$36.50	PB1.2x	E-21.6%	n/a
AIM AIM ImmunoTech	US$0.49	-0.3%	19.2%	US$24.6m	US$2.75	PS120.8x	E9.4%	n/a

Global Pharmaceuticals & Biotech Strong Balance Sheet Stocks